Effect of Aprotinin on Transfusion Requirements and Blood Loss in Patients Undergoing Elective Primary Total Hip Replacement

NCT00668031 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

359

Enrollment

INDUSTRY

Sponsor class

Conditions

Blood Loss, Surgical

Interventions

DRUG: Trasylol (Aprotinin, BAYA0128)
DRUG: Placebo

Sponsor

Bayer